Tokai Central Hospital
In research, Tokai Central Hospital stands highest in Health Sciences (#19,283 of 20,462 worldwide) and Medicine (#17,558 of 17,978 worldwide), over all time.
- World rank, all time
- #38,553 of 42,892
- Rank in Japan
- #1,762 of 2,112
- Research works
- 172 ▼ 18% vs 2013–17
- Citations
- 2.2k 12.9 per fractional work
- Top-10% rate
- 23.5% record average 16.5%
- Open access
- 57% world 28%
What is Tokai Central Hospital known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #19,283 of 20,462 | 6.9% | 130 | |
| MedicineField | #17,558 of 17,978 | 6.0% | 123 |
Each strip is that field’s whole ranked pool, with the notch where Tokai Central Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Psychology, 4.6×. Every wedge is a field page.
- Psychology 4.6×
- Health Professions 3.5×
- Medicine 3.2×
- Nursing 2.1×
- Neuroscience 1.4×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Chemistry 0.4×
- Immunology and Microbiology 0.2×
- Engineering 0.2×
- Social Sciences 0.2×
- Materials Science 0.2×
- Business, Management and Accounting 0.1×
- Mathematics 0.1×
- Economics, Econometrics and Finance 0.1×
Who are the top researchers at Tokai Central Hospital?
Ranked on the composite score, Junichi Sakamoto lead among researchers whose main affiliation is Tokai Central Hospital.
- 1 Junichi Sakamoto Japan · #1,043,672 worldwide 39 citations · 57 works
Which keywords describe research at Tokai Central Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Surgical Management, Prognostic Factors, Survival Analysis, Epidemiology, Quality of Life and Molecular Characterization.
- Treatment Guidelines
- Adjuvant Chemotherapy
- Prognosis
- Preoperative Chemoradiotherapy
- Laparoscopic Surgery
- Fluorouracil
- PDGFRA Mutations
- Cetuximab
- Clinical Trials
- Precision Medicine
- Lymph Node Dissection
- Neoadjuvant Chemotherapy
- Adjuvant Therapy
- Neoadjuvant Therapy
- Endoscopic Resection
- Immunotherapy
- Treatment
- Prognostic Factors
- Quality of Life
- Epidemiology
- Chemotherapy
- Clinical Practice Guidelines
- Surgical Management
- Survival Analysis
- Molecular Characterization
- Gastric Cancer
- Genetic Mutations
- Diagnosis
- Cardiovascular Disease
- PET Imaging
- Metastatic Gastric Cancer
- Depression
- Imatinib Mesylate
- Molecular Subtypes
- Sunitinib
- KRAS Mutations
- Tumor Microenvironment
- Targeted Therapy
- Neural Correlates
- Chemoradiation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy19▲ 16×18 topics
- Epidemiology15▲ 2.1×52 topics
- Clinical Practice Guidelines11▲ 11×11 topics
- Quality of Life10▲ 4.2×21 topics
- Surgical Management9▲ 12×13 topics
- Prognostic Factors9▲ 11×11 topics
- Survival Analysis8▲ 18×4 topics
- Treatment8▲ 3.7×25 topics
- Molecular Characterization7▲ 23×5 topics
- Immunotherapy7▲ 6.4×15 topics
- Gastric Cancer7▲ 32×3 topics
- Endoscopic Resection7▲ 41×2 topics
- Genetic Mutations7▲ 7.5×14 topics
- Neoadjuvant Therapy6▲ 17×5 topics
- Diagnosis6▲ 3.5×23 topics
- Adjuvant Therapy6▲ 30×2 topics
- Cardiovascular Disease6▲ 2.9×15 topics
- Neoadjuvant Chemotherapy6▲ 37×2 topics
- PET Imaging6▲ 15×4 topics
- Lymph Node Dissection5▲ 54×1 topic
- Metastatic Gastric Cancer5▲ 54×1 topic
- Precision Medicine5▲ 9.4×2 topics
- Depression5▲ 3.7×12 topics
- Clinical Trials4▲ 4.2×9 topics
- Imatinib Mesylate4▲ 45×2 topics
- Cetuximab4▲ 29×2 topics
- Molecular Subtypes4▲ 27×3 topics
- PDGFRA Mutations4▲ 81×1 topic
- Sunitinib4▲ 81×1 topic
- Fluorouracil4▲ 69×1 topic
- KRAS Mutations4▲ 69×1 topic
- Laparoscopic Surgery4▲ 20×4 topics
- Tumor Microenvironment4▲ 6.2×7 topics
- Preoperative Chemoradiotherapy4▲ 30×2 topics
- Targeted Therapy4▲ 9.5×5 topics
- Prognosis3▲ 6.2×9 topics
- Neural Correlates3▲ 20×4 topics
- Adjuvant Chemotherapy3▲ 25×2 topics
- Chemoradiation3▲ 31×2 topics
- Treatment Guidelines3▲ 8.6×3 topics
Which research topics does Tokai Central Hospital publish most on?
By volume in 2022–2025: COVID-19 and Mental Health, Palliative Care and End-of-Life Issues, Gastric Cancer Management and Outcomes and School Health and Nursing Education.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 COVID-19 and Mental Health Clinical Psychology 2 works
- 2 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 1 works
- 3 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 1 works
- 4 School Health and Nursing Education Speech and Hearing 1 works
- 5 Gastrointestinal Tumor Research and Treatment Gastroenterology 1 works
- 6 Technostress in Professional Settings Social Psychology 0 works
- 7 Long-Term Effects of COVID-19 Neurology 0 works
- 8 Menopause: Health Impacts and Treatments Endocrinology, Diabetes and Metabolism 0 works
- 9 Colorectal Cancer Treatments and Studies Oncology 0 works
- 10 Esophageal Cancer Research and Treatment Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tokai Central Hospital's research output changed?
Output in 2018–2022 was 18% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Kakamigahara
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.